Weekly Research Analysts’ Ratings Changes for Thermo Fisher Scientific (TMO)

Posted by on Jul 27th, 2026

Thermo Fisher Scientific (NYSE: TMO) recently received a number of ratings updates from brokerages and research firms:

  • 7/24/2026 – Thermo Fisher Scientific had its “overweight” rating reaffirmed by Morgan Stanley. They now have a $650.00 price target on the stock.
  • 7/24/2026 – Thermo Fisher Scientific had its price target raised by Royal Bank Of Canada from $490.00 to $580.00. They now have a “sector perform” rating on the stock.
  • 7/24/2026 – Thermo Fisher Scientific had its price target raised by Barclays PLC from $625.00 to $650.00. They now have an “overweight” rating on the stock.
  • 7/23/2026 – Thermo Fisher Scientific had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $630.00 price target on the stock.
  • 7/14/2026 – Thermo Fisher Scientific was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
  • 7/6/2026 – Thermo Fisher Scientific was given a new $570.00 price target by Evercore Inc.
  • 6/29/2026 – Thermo Fisher Scientific was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
  • 6/26/2026 – Thermo Fisher Scientific is now covered by Sanford C. Bernstein. They set a “market perform” rating and a $520.00 price target on the stock.
  • 6/25/2026 – Thermo Fisher Scientific was upgraded by Sanford C. Bernstein to “hold”.
  • 6/11/2026 – Thermo Fisher Scientific is now covered by Piper Sandler. They set a “neutral” rating and a $510.00 price target on the stock.
  • 6/11/2026 – Thermo Fisher Scientific is now covered by Piper Sandler. They set a “neutral” rating and a $510.00 price target on the stock.
  • 6/3/2026 – Thermo Fisher Scientific was downgraded by HSBC Holdings plc from “buy” to “hold”. They now have a $540.00 price target on the stock, down from $670.00.
  • 6/3/2026 – Thermo Fisher Scientific was downgraded by HSBC Holdings plc from “buy” to “hold”. They now have a $540.00 price target on the stock, down from $670.00.
  • 6/2/2026 – Thermo Fisher Scientific is now covered by Wolfe Research. They set an “outperform” rating and a $535.00 price target on the stock.
  • 6/1/2026 – Thermo Fisher Scientific was upgraded by Wolfe Research to “strong-buy”.

Thermo Fisher Scientific Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Tuesday, September 15th will be paid a $0.47 dividend. This represents a $1.88 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 15th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.11%.

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.

Featured Stories

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.